| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.804 | 0.005 | 0.804 | Analgesic | 0.741 0.01 DBMET02304 0.759 0.008 DBMET00734 0.695 0.014 DBMET02305 0.457 0.063 DBMET02294 | ||
| 0.771 | 0.004 | 0.783 | Psychostimulant | 0.655 0.005 DBMET02304 0.783 0.004 DBMET00734 0.653 0.005 DBMET02305 0.439 0.017 DBMET02294 | DBMET00734 | |
| 0.758 | 0.003 | 0.758 | 5 Hydroxytryptamine uptake inhibitor | 0.646 0.004 DBMET02304 0.641 0.004 DBMET00734 0.515 0.004 DBMET02305 0.373 0.005 DBMET02294 | ||
| 0.625 | 0.004 | 0.625 | Calcium channel L-type activator | 0.524 0.02 DBMET02304 0.617 0.005 DBMET00734 0.543 0.015 DBMET02305 0.528 0.018 DBMET02294 | ||
| 0.622 | 0.003 | 0.622 | Adrenaline uptake inhibitor | 0.438 0.004 DBMET02304 0.504 0.003 DBMET00734 0.329 0.004 DBMET02305 0.295 0.004 DBMET02294 | ||
| 0.566 | 0.009 | 0.595 | Vasodilator, coronary | 0.499 0.015 DBMET02304 0.592 0.008 DBMET00734 0.502 0.015 DBMET02305 0.595 0.008 DBMET02294 | DBMET02294 | |
| 0.421 | 0.002 | 0.421 | Toll-Like receptor 3 antagonist | 0.369 0.003 DBMET02304 0.342 0.003 DBMET00734 0.294 0.004 DBMET02305 0.249 0.004 DBMET02294 | ||
| 0.418 | 0.004 | 0.418 | 5 Hydroxytryptamine 1E antagonist | 0.353 0.009 DBMET02304 0.386 0.005 DBMET00734 0.341 0.012 DBMET02305 | ||
| 0.444 | 0.037 | 0.452 | 5 Hydroxytryptamine release stimulant | 0.436 0.039 DBMET02304 0.396 0.047 DBMET00734 0.452 0.036 DBMET02305 0.44 0.038 DBMET02294 | DBMET02305 | |
| 0.417 | 0.019 | 0.417 | Calcium channel activator | 0.37 0.038 DBMET02304 0.403 0.023 DBMET00734 0.351 0.049 DBMET02305 | ||
| 0.386 | 0.005 | 0.386 | Alpha 2b adrenoreceptor antagonist | 0.23 0.018 DBMET02304 0.313 0.008 DBMET00734 0.191 0.026 DBMET02305 | ||
| 0.376 | 0.008 | 0.376 | Anesthetic local | 0.252 0.019 DBMET02304 0.343 0.009 DBMET00734 0.23 0.024 DBMET02305 | ||
| 0.365 | 0.004 | 0.367 | Inducible nitric-oxide synthase inhibitor | 0.367 0.004 DBMET02304 0.312 0.004 DBMET00734 0.315 0.004 DBMET02305 0.079 0.064 DBMET02294 | DBMET02304 | |
| 0.4 | 0.064 | 0.727 | Transcription factor NF kappa B inhibitor | 0.408 0.062 DBMET02304 0.527 0.04 DBMET00734 0.51 0.043 DBMET02305 0.727 0.018 DBMET02294 | DBMET02294 | |
| 0.393 | 0.057 | 0.419 | Vasodilator, peripheral | 0.256 0.123 DBMET02304 0.419 0.049 DBMET00734 0.261 0.119 DBMET02305 0.252 0.126 DBMET02294 | DBMET00734 | |
| 0.419 | 0.085 | 0.419 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.327 0.178 DBMET02304 0.288 0.23 DBMET00734 | ||
| 0.361 | 0.028 | 0.397 | Anticonvulsant | 0.397 0.022 DBMET02304 0.205 0.079 DBMET00734 0.263 0.052 DBMET02305 | DBMET02304 | |
| 0.336 | 0.004 | 0.336 | Nitric-oxide synthase inhibitor | 0.333 0.004 DBMET02304 0.269 0.005 DBMET00734 0.268 0.005 DBMET02305 | ||
| 0.343 | 0.013 | 0.403 | Peptidyltransferase inhibitor | 0.36 0.011 DBMET02304 0.346 0.013 DBMET00734 0.363 0.01 DBMET02305 0.403 0.007 DBMET02294 | DBMET02294 | |
| 0.36 | 0.05 | 0.509 | Spasmolytic | 0.259 0.087 DBMET02304 0.425 0.035 DBMET00734 0.3 0.07 DBMET02305 0.509 0.022 DBMET02294 | DBMET02294 | |
| 0.337 | 0.042 | 0.502 | Antiamyloidogenic | 0.323 0.045 DBMET02304 0.447 0.022 DBMET00734 0.4 0.028 DBMET02305 0.502 0.016 DBMET02294 | DBMET02294 | |
| 0.369 | 0.078 | 0.38 | Antiobesity | 0.38 0.073 DBMET02304 0.296 0.119 DBMET00734 0.304 0.114 DBMET02305 0.276 0.134 DBMET02294 | DBMET02304 | |
| 0.297 | 0.014 | 0.297 | Antiadrenergic | 0.208 0.023 DBMET02304 0.226 0.02 DBMET00734 0.173 0.03 DBMET02305 | ||
| 0.29 | 0.014 | 0.29 | Adrenaline antagonist | 0.203 0.023 DBMET02304 0.22 0.02 DBMET00734 0.169 0.03 DBMET02305 | ||
| 0.271 | 0.008 | 0.271 | Alpha 2c adrenoreceptor antagonist | 0.172 0.024 DBMET02304 0.227 0.013 DBMET00734 0.147 0.033 DBMET02305 0.091 0.074 DBMET02294 | ||
| 0.262 | 0.02 | 0.262 | 5 Hydroxytryptamine 2 antagonist | 0.15 0.044 DBMET02304 0.162 0.04 DBMET00734 0.089 0.081 DBMET02305 | ||
| 0.292 | 0.052 | 0.365 | Interleukin agonist | 0.365 0.025 DBMET02304 0.302 0.047 DBMET00734 0.361 0.026 DBMET02305 0.32 0.039 DBMET02294 | DBMET02304 | |
| 0.291 | 0.051 | 0.324 | Vasodilator | 0.257 0.065 DBMET02304 0.309 0.045 DBMET00734 0.276 0.057 DBMET02305 0.324 0.041 DBMET02294 | DBMET02294 | |
| 0.288 | 0.053 | 0.288 | Ca(v)3.3 blocker | 0.259 0.087 DBMET02304 0.236 0.123 DBMET00734 | ||
| 0.229 | 0.005 | 0.229 | Dopamine uptake inhibitor | 0.132 0.012 DBMET02304 0.164 0.009 DBMET00734 0.102 0.018 DBMET02305 | ||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | 0.226 0.031 DBMET02304 0.179 0.108 DBMET00734 0.176 0.118 DBMET02305 | ||
| 0.227 | 0.005 | 0.299 | Adrenaline agonist | 0.155 0.013 DBMET02304 0.299 0.004 DBMET00734 0.217 0.005 DBMET02305 | DBMET00734 | |
| 0.246 | 0.026 | 0.246 | Antipruritic | 0.245 0.026 DBMET02304 0.235 0.03 DBMET00734 0.24 0.028 DBMET02305 | ||
| 0.24 | 0.028 | 0.245 | Acetylcholine M1 receptor antagonist | 0.239 0.028 DBMET02304 0.231 0.03 DBMET00734 0.245 0.026 DBMET02305 0.117 0.113 DBMET02294 | DBMET02305 | |
| 0.217 | 0.007 | 0.217 | Alpha adrenoreceptor agonist | 0.155 0.015 DBMET02304 0.2 0.009 DBMET00734 0.143 0.017 DBMET02305 | ||
| 0.221 | 0.015 | 0.255 | Interleukin 1b antagonist | 0.255 0.012 DBMET02304 0.181 0.024 DBMET00734 0.209 0.018 DBMET02305 0.146 0.043 DBMET02294 | DBMET02304 | |
| 0.214 | 0.015 | 0.214 | Alpha 2 adrenoreceptor antagonist | 0.123 0.035 DBMET02304 0.161 0.024 DBMET00734 0.1 0.048 DBMET02305 | ||
| 0.346 | 0.149 | 0.606 | Caspase 9 stimulant | 0.39 0.117 DBMET02304 0.403 0.109 DBMET00734 0.439 0.089 DBMET02305 0.606 0.035 DBMET02294 | DBMET02294 | |
| 0.207 | 0.011 | 0.233 | Adenylate cyclase stimulant | 0.203 0.012 DBMET02304 0.233 0.005 DBMET00734 0.224 0.006 DBMET02305 0.181 0.025 DBMET02294 | DBMET00734 | |
| 0.289 | 0.099 | 0.34 | Cholesterol antagonist | 0.29 0.098 DBMET02304 0.34 0.069 DBMET00734 0.336 0.07 DBMET02305 0.34 0.069 DBMET02294 | DBMET02294 | |
| 0.202 | 0.017 | 0.202 | 5 Hydroxytryptamine 1 antagonist | 0.111 0.033 DBMET02304 0.104 0.036 DBMET00734 0.064 0.059 DBMET02305 | ||
| 0.19 | 0.004 | 0.252 | Beta adrenoreceptor antagonist | 0.137 0.007 DBMET02304 0.252 0.003 DBMET00734 0.175 0.005 DBMET02305 0.071 0.036 DBMET02294 | DBMET00734 | |
| 0.211 | 0.026 | 0.211 | Alpha adrenoreceptor antagonist | 0.101 0.056 DBMET02304 0.142 0.04 DBMET00734 | ||
| 0.296 | 0.119 | 0.367 | GABA C receptor rho-3 antagonist | 0.329 0.097 DBMET02304 0.295 0.119 DBMET00734 0.367 0.077 DBMET02305 | DBMET02305 | |
| 0.196 | 0.02 | 0.196 | 5 Hydroxytryptamine 2A antagonist | 0.114 0.04 DBMET02304 0.113 0.041 DBMET00734 | ||
| 0.321 | 0.145 | 0.636 | Cyclophilin D inhibitor | 0.382 0.101 DBMET02304 0.351 0.121 DBMET00734 0.397 0.093 DBMET02305 0.636 0.022 DBMET02294 | DBMET02294 | |
| 0.245 | 0.073 | 0.363 | Tyrosine 3 hydroxylase inhibitor | 0.303 0.032 DBMET02304 0.302 0.032 DBMET00734 0.363 0.013 DBMET02305 | DBMET02305 | |
| 0.251 | 0.08 | 0.332 | 5 Hydroxytryptamine uptake stimulant | 0.332 0.031 DBMET02304 0.241 0.09 DBMET00734 0.315 0.038 DBMET02305 | DBMET02304 | |
| 0.184 | 0.016 | 0.184 | Alpha 2a adrenoreceptor antagonist | 0.107 0.033 DBMET02304 0.15 0.022 DBMET00734 0.094 0.04 DBMET02305 | ||
| 0.293 | 0.127 | 0.433 | Histamine release inhibitor | 0.383 0.084 DBMET02304 0.346 0.102 DBMET00734 0.433 0.059 DBMET02305 0.241 0.162 DBMET02294 | DBMET02305 | |
| 0.18 | 0.014 | 0.309 | Sphingomyelinase inhibitor | 0.124 0.038 DBMET02304 0.163 0.02 DBMET00734 0.101 0.059 DBMET02305 0.309 0.003 DBMET02294 | DBMET02294 | |
| 0.244 | 0.08 | 0.48 | Hypoglycemic | 0.344 0.039 DBMET02304 0.295 0.054 DBMET00734 0.378 0.032 DBMET02305 0.48 0.017 DBMET02294 | DBMET02294 | |
| 0.198 | 0.034 | 0.198 | 5 Hydroxytryptamine antagonist | 0.119 0.065 DBMET02304 0.099 0.08 DBMET00734 | ||
| 0.166 | 0.004 | 0.209 | Beta 1 adrenoreceptor antagonist | 0.112 0.008 DBMET02304 0.209 0.003 DBMET00734 0.138 0.005 DBMET02305 | DBMET00734 | |
| 0.163 | 0.004 | 0.176 | Glycine transporter 1 inhibitor | 0.176 0.004 DBMET02304 0.107 0.005 DBMET00734 0.112 0.005 DBMET02305 | DBMET02304 | |
| 0.171 | 0.013 | 0.171 | 5 Hydroxytryptamine 1F antagonist | 0.096 0.033 DBMET02304 0.111 0.027 DBMET00734 | ||
| 0.178 | 0.021 | 0.178 | 5 Hydroxytryptamine 2C antagonist | 0.117 0.037 DBMET02304 0.108 0.041 DBMET00734 0.072 0.07 DBMET02305 | ||
| 0.212 | 0.062 | 0.263 | Insulin sensitizer | 0.253 0.033 DBMET02304 0.23 0.048 DBMET00734 0.263 0.028 DBMET02305 | DBMET02305 | |
| 0.307 | 0.157 | 0.438 | 5 Hydroxytryptamine release inhibitor | 0.423 0.065 DBMET02304 0.307 0.157 DBMET00734 0.438 0.057 DBMET02305 | DBMET02305 | |
| 0.169 | 0.019 | 0.423 | NMDA receptor antagonist | 0.268 0.008 DBMET02304 0.254 0.009 DBMET00734 0.423 0.004 DBMET02305 | DBMET02305 | |
| 0.208 | 0.059 | 0.217 | P-glycoprotein inhibitor | 0.172 0.088 DBMET02304 0.217 0.055 DBMET00734 0.172 0.088 DBMET02305 0.184 0.076 DBMET02294 | DBMET00734 | |
| 0.174 | 0.026 | 0.174 | Antihistaminic | 0.095 0.059 DBMET02304 0.083 0.073 DBMET00734 | ||
| 0.157 | 0.01 | 0.157 | Glutamate (mGluR7) agonist | 0.116 0.034 DBMET02304 0.122 0.029 DBMET00734 | ||
| 0.213 | 0.069 | 0.284 | Nitric-oxide synthase stimulant | 0.231 0.047 DBMET02304 0.232 0.047 DBMET00734 0.247 0.035 DBMET02305 0.284 0.016 DBMET02294 | DBMET02294 | |
| 0.158 | 0.014 | 0.311 | Protein kinase B gamma inhibitor | 0.311 0.004 DBMET02304 0.109 0.029 DBMET00734 0.223 0.006 DBMET02305 | DBMET02304 | |
| 0.159 | 0.019 | 0.159 | 5 Hydroxytryptamine 1A antagonist | 0.104 0.031 DBMET02304 0.088 0.036 DBMET00734 0.064 0.05 DBMET02305 | ||
| 0.143 | 0.005 | 0.198 | Beta 2 adrenoreceptor antagonist | 0.098 0.008 DBMET02304 0.198 0.004 DBMET00734 0.14 0.005 DBMET02305 0.051 0.035 DBMET02294 | DBMET00734 | |
| 0.142 | 0.006 | 0.142 | Dopamine transporter inhibitor | 0.098 0.012 DBMET02304 0.108 0.01 DBMET00734 0.075 0.019 DBMET02305 | ||
| 0.205 | 0.072 | 0.303 | Neurotrophic factor enhancer | 0.201 0.075 DBMET02304 0.259 0.034 DBMET00734 0.243 0.042 DBMET02305 0.303 0.017 DBMET02294 | DBMET02294 | |
| 0.16 | 0.027 | 0.16 | Histamine antagonist | 0.083 0.061 DBMET02304 | ||
| 0.175 | 0.044 | 0.234 | Interleukin 1 antagonist | 0.234 0.022 DBMET02304 0.154 0.055 DBMET00734 0.209 0.029 DBMET02305 0.111 0.104 DBMET02294 | DBMET02304 | |
| 0.173 | 0.043 | 0.173 | Calcium channel blocker | 0.126 0.081 DBMET02304 0.112 0.097 DBMET00734 | ||
| 0.175 | 0.045 | 0.175 | Nav1.2 sodium channel blocker | 0.155 0.054 DBMET02304 0.128 0.075 DBMET00734 0.122 0.081 DBMET02305 | ||
| 0.139 | 0.009 | 0.139 | Acetylcholine M5 receptor antagonist | 0.093 0.019 DBMET02304 0.111 0.015 DBMET00734 0.078 0.025 DBMET02305 | ||
| 0.15 | 0.022 | 0.15 | Alpha 1b adrenoreceptor antagonist | 0.072 0.051 DBMET02304 0.097 0.036 DBMET00734 | ||
| 0.162 | 0.036 | 0.162 | 5 Hydroxytryptamine 2B antagonist | 0.128 0.053 DBMET02304 0.12 0.06 DBMET00734 0.096 0.088 DBMET02305 | ||
| 0.206 | 0.081 | 0.452 | Interleukin antagonist | 0.425 0.027 DBMET02304 0.255 0.06 DBMET00734 0.452 0.024 DBMET02305 0.236 0.067 DBMET02294 | DBMET02305 | |
| 0.22 | 0.095 | 0.531 | Aldehyde oxidase inhibitor | 0.308 0.064 DBMET02304 0.446 0.04 DBMET00734 0.531 0.029 DBMET02305 | DBMET02305 | |
| 0.171 | 0.05 | 0.171 | Toll-Like receptor 9 antagonist | 0.112 0.095 DBMET00734 | ||
| 0.147 | 0.03 | 0.147 | Alpha 1 adrenoreceptor antagonist | 0.088 0.048 DBMET00734 | ||
| 0.124 | 0.008 | 0.124 | Glycine transporter inhibitor | 0.099 0.012 DBMET02304 0.073 0.019 DBMET00734 0.054 0.028 DBMET02305 | ||
| 0.194 | 0.078 | 0.295 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.249 0.043 DBMET02304 0.255 0.04 DBMET00734 0.295 0.025 DBMET02305 0.153 0.143 DBMET02294 | DBMET02305 | |
| 0.155 | 0.041 | 0.156 | Acetylcholine muscarinic antagonist | 0.135 0.054 DBMET02304 0.156 0.04 DBMET00734 0.14 0.05 DBMET02305 | DBMET00734 | |
| 0.122 | 0.01 | 0.122 | Alpha 2 adrenoreceptor agonist | 0.094 0.017 DBMET02304 0.103 0.014 DBMET00734 0.084 0.022 DBMET02305 | ||
| 0.175 | 0.064 | 0.192 | ATPase inhibitor | 0.192 0.044 DBMET00734 0.184 0.052 DBMET02294 | DBMET00734 | |
| 0.149 | 0.039 | 0.172 | Vanilloid 1 agonist | 0.143 0.046 DBMET02304 0.172 0.022 DBMET00734 0.156 0.033 DBMET02305 0.146 0.043 DBMET02294 | DBMET00734 | |
| 0.127 | 0.018 | 0.135 | Glutamate release inhibitor | 0.135 0.014 DBMET02304 0.1 0.043 DBMET00734 0.117 0.024 DBMET02305 | DBMET02304 | |
| 0.122 | 0.012 | 0.122 | Alpha 1 adrenoreceptor agonist | 0.072 0.027 DBMET02304 0.096 0.018 DBMET00734 0.06 0.036 DBMET02305 | ||
| 0.134 | 0.025 | 0.134 | Acetylcholine nicotinic antagonist | 0.111 0.033 DBMET02304 0.103 0.037 DBMET00734 0.084 0.05 DBMET02305 | ||
| 0.153 | 0.046 | 0.153 | Nav1.3 sodium channel blocker | 0.11 0.086 DBMET00734 | ||
| 0.211 | 0.109 | 0.211 | Cardiotonic | 0.162 0.161 DBMET02304 0.175 0.145 DBMET00734 0.188 0.131 DBMET02294 | ||
| 0.109 | 0.008 | 0.132 | Factor IXa inhibitor | 0.132 0.005 DBMET02304 0.1 0.01 DBMET00734 0.125 0.005 DBMET02305 0.079 0.016 DBMET02294 | DBMET02304 | |
| 0.108 | 0.013 | 0.142 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 DBMET02304 0.142 0.007 DBMET00734 0.084 0.021 DBMET02305 | DBMET00734 | |
| 0.133 | 0.038 | 0.178 | Bronchodilator | 0.099 0.065 DBMET02304 0.155 0.03 DBMET00734 0.112 0.05 DBMET02305 0.178 0.023 DBMET02294 | DBMET02294 | |
| 0.133 | 0.04 | 0.133 | Nav1.5 sodium channel blocker | 0.129 0.044 DBMET02304 0.101 0.083 DBMET00734 0.096 0.092 DBMET02305 | ||
| 0.113 | 0.02 | 0.113 | Alpha 1d adrenoreceptor antagonist | 0.052 0.047 DBMET02304 0.063 0.038 DBMET00734 | ||
| 0.147 | 0.054 | 0.147 | Cholinergic antagonist | 0.121 0.073 DBMET02304 0.141 0.058 DBMET00734 0.118 0.075 DBMET02305 | ||
| 0.146 | 0.057 | 0.146 | Acetylcholinesterase inhibitor | 0.138 0.063 DBMET00734 | ||
| 0.214 | 0.127 | 0.328 | Lipoxygenase inhibitor | 0.231 0.113 DBMET02304 0.328 0.058 DBMET00734 0.327 0.059 DBMET02305 | DBMET00734 | |
| 0.141 | 0.055 | 0.141 | Acetylcholine antagonist | 0.118 0.072 DBMET02304 0.135 0.059 DBMET00734 0.115 0.075 DBMET02305 | ||
| 0.145 | 0.059 | 0.145 | Nav1.6 sodium channel blocker | 0.136 0.072 DBMET02304 0.123 0.091 DBMET00734 | ||
| 0.213 | 0.129 | 0.213 | Gastrin inhibitor | |||
| 0.125 | 0.041 | 0.127 | Electron transport complex I inhibitor | 0.109 0.063 DBMET02304 0.127 0.038 DBMET00734 0.103 0.076 DBMET02305 | DBMET00734 | |
| 0.125 | 0.041 | 0.159 | Urease inhibitor | 0.142 0.027 DBMET02304 0.143 0.027 DBMET00734 0.159 0.019 DBMET02305 | DBMET02305 | |
| 0.143 | 0.064 | 0.157 | Ca2+-transporting ATPase inhibitor | 0.154 0.034 DBMET02304 0.141 0.069 DBMET00734 0.157 0.029 DBMET02305 | DBMET02305 | |
| 0.116 | 0.037 | 0.116 | Calcium antagonist | 0.103 0.046 DBMET02304 | ||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | |||
| 0.119 | 0.041 | 0.144 | Anabolic | 0.132 0.029 DBMET02304 0.131 0.03 DBMET00734 0.144 0.021 DBMET02305 | DBMET02305 | |
| 0.106 | 0.03 | 0.106 | Histamine H2 receptor antagonist | 0.085 0.055 DBMET00734 | ||
| 0.1 | 0.025 | 0.233 | Phenylalanine 4-hydroxylase inhibitor | 0.147 0.012 DBMET02304 0.171 0.009 DBMET00734 0.233 0.005 DBMET02305 | DBMET02305 | |
| 0.124 | 0.05 | 0.197 | Mucolytic | 0.175 0.021 DBMET02304 0.141 0.038 DBMET00734 0.197 0.014 DBMET02305 0.125 0.05 DBMET02294 | DBMET02305 | |
| 0.098 | 0.025 | 0.098 | Neuronal nicotinic receptor antagonist | 0.085 0.032 DBMET02304 0.078 0.038 DBMET00734 0.064 0.05 DBMET02305 | ||
| 0.136 | 0.063 | 0.136 | Sphingosine 1-phosphate receptor 2 antagonist | 0.132 0.069 DBMET02304 0.134 0.066 DBMET00734 0.128 0.078 DBMET02305 | ||
| 0.18 | 0.11 | 0.194 | Hypolipemic | 0.182 0.108 DBMET02304 0.193 0.1 DBMET00734 0.194 0.099 DBMET02305 0.193 0.1 DBMET02294 | DBMET02305 | |
| 0.143 | 0.073 | 0.35 | Protein kinase stimulant | 0.195 0.043 DBMET02304 0.192 0.045 DBMET00734 0.246 0.027 DBMET02305 0.35 0.012 DBMET02294 | DBMET02294 | |
| 0.138 | 0.069 | 0.179 | Farnesoid X receptor antagonist | 0.146 0.057 DBMET02304 0.177 0.031 DBMET00734 0.179 0.03 DBMET02305 | DBMET02305 | |
| 0.097 | 0.028 | 0.122 | Estrogen-related receptor beta agonist | 0.087 0.046 DBMET02304 0.122 0.009 DBMET00734 0.107 0.017 DBMET02305 0.08 0.067 DBMET02294 | DBMET00734 | |
| 0.09 | 0.021 | 0.115 | Acetylcholine M3 receptor antagonist | 0.068 0.033 DBMET02304 0.115 0.015 DBMET00734 0.085 0.024 DBMET02305 | DBMET00734 | |
| 0.077 | 0.011 | 0.095 | Beta 2 adrenoreceptor agonist | 0.071 0.017 DBMET02304 0.095 0.005 DBMET00734 0.084 0.007 DBMET02305 | DBMET00734 | |
| 0.088 | 0.022 | 0.088 | Carbonic anhydrase stimulant | 0.085 0.024 DBMET02304 0.076 0.028 DBMET00734 0.071 0.031 DBMET02305 | ||
| 0.127 | 0.062 | 0.274 | Alkylator | 0.125 0.064 DBMET02304 0.143 0.05 DBMET00734 0.143 0.05 DBMET02305 0.274 0.014 DBMET02294 | DBMET02294 | |
| 0.068 | 0.003 | 0.068 | Alpha 2a adrenoreceptor agonist | 0.056 0.004 DBMET02304 0.061 0.004 DBMET00734 0.046 0.004 DBMET02305 | ||
| 0.086 | 0.022 | 0.088 | Potassium channel (Tandem pore domain) blocker | 0.088 0.02 DBMET02304 0.072 0.058 DBMET02305 | DBMET02304 | |
| 0.163 | 0.101 | 0.304 | Anesthetic general | 0.179 0.088 DBMET02304 0.186 0.082 DBMET00734 0.211 0.069 DBMET02305 0.304 0.032 DBMET02294 | DBMET02294 | |
| 0.129 | 0.068 | 0.129 | Antibacterial (Helicobacter pylori) | 0.129 0.069 DBMET02304 0.127 0.071 DBMET00734 0.124 0.075 DBMET02305 0.116 0.088 DBMET02294 | ||
| 0.22 | 0.162 | 0.312 | Sodium/bile acid cotransporter inhibitor | 0.312 0.069 DBMET00734 0.277 0.101 DBMET02305 | DBMET00734 | |
| 0.145 | 0.088 | 0.287 | Melanin inhibitor | 0.19 0.045 DBMET02304 0.194 0.043 DBMET00734 0.287 0.024 DBMET02305 0.275 0.025 DBMET02294 | DBMET02305 | |
| 0.088 | 0.032 | 0.088 | Calcium channel L-type blocker | |||
| 0.11 | 0.053 | 0.11 | Gastric antisecretory | 0.097 0.07 DBMET00734 | ||
| 0.171 | 0.115 | 0.171 | Potassium channel blocker | |||
| 0.142 | 0.086 | 0.142 | GABA C receptor rho-2 antagonist | 0.132 0.102 DBMET00734 | ||
| 0.084 | 0.029 | 0.084 | 5 Hydroxytryptamine 1D antagonist | 0.056 0.054 DBMET02304 | ||
| 0.1 | 0.046 | 0.1 | Polo-like kinase-1 inhibitor | 0.095 0.052 DBMET02304 0.087 0.068 DBMET00734 | ||
| 0.093 | 0.039 | 0.134 | CYP2A6 inhibitor | 0.134 0.021 DBMET02304 0.089 0.042 DBMET02305 | DBMET02304 | |
| 0.079 | 0.026 | 0.079 | TRPA1 antagonist | 0.069 0.033 DBMET00734 | ||
| 0.116 | 0.063 | 0.152 | TRPA1 agonist | 0.138 0.04 DBMET02304 0.139 0.039 DBMET00734 0.152 0.03 DBMET02305 | DBMET02305 | |
| 0.061 | 0.009 | 0.071 | Diamine oxidase inhibitor | 0.071 0.006 DBMET02304 0.041 0.022 DBMET00734 0.047 0.016 DBMET02305 | DBMET02304 | |
| 0.066 | 0.017 | 0.156 | NMDA receptor subunit 3B antagonist | 0.073 0.015 DBMET02304 0.123 0.008 DBMET00734 0.156 0.005 DBMET02305 | DBMET02305 | |
| 0.06 | 0.011 | 0.06 | Alpha 1d adrenoreceptor agonist | 0.058 0.012 DBMET02304 0.056 0.013 DBMET00734 0.051 0.016 DBMET02305 | ||
| 0.106 | 0.063 | 0.2 | Expectorant | 0.159 0.032 DBMET02304 0.129 0.045 DBMET00734 0.192 0.022 DBMET02305 0.2 0.02 DBMET02294 | DBMET02294 | |
| 0.085 | 0.042 | 0.085 | Alpha 1a adrenoreceptor antagonist | |||
| 0.08 | 0.037 | 0.08 | Sphingosine 1-phosphate receptor 4 agonist | 0.073 0.042 DBMET02304 0.059 0.056 DBMET02305 | ||
| 0.059 | 0.017 | 0.125 | NMDA receptor subunit 3A antagonist | 0.063 0.016 DBMET02304 0.103 0.008 DBMET00734 0.125 0.006 DBMET02305 | DBMET02305 | |
| 0.197 | 0.155 | 0.262 | Hypoxia-inducible factor 1 alpha inhibitor | 0.262 0.09 DBMET00734 0.213 0.137 DBMET02305 0.229 0.12 DBMET02294 | DBMET00734 | |
| 0.208 | 0.167 | 0.584 | Antithrombotic | 0.234 0.14 DBMET02304 0.233 0.141 DBMET00734 0.257 0.121 DBMET02305 0.584 0.018 DBMET02294 | DBMET02294 | |
| 0.119 | 0.078 | 0.221 | Cyclooxygenase 3 inhibitor | 0.174 0.031 DBMET02304 0.131 0.065 DBMET00734 0.183 0.026 DBMET02305 0.221 0.013 DBMET02294 | DBMET02294 | |
| 0.064 | 0.023 | 0.138 | Glycine transporter 2 inhibitor | 0.101 0.013 DBMET02304 0.092 0.014 DBMET00734 0.138 0.009 DBMET02305 | DBMET02305 | |
| 0.054 | 0.018 | 0.054 | Histamine H2 receptor agonist | 0.041 0.032 DBMET02304 | ||
| 0.079 | 0.043 | 0.079 | Vanilloid 4 agonist | |||
| 0.055 | 0.019 | 0.073 | Cytokine production stimulant | 0.073 0.006 DBMET02304 0.061 0.012 DBMET02305 0.05 0.03 DBMET02294 | DBMET02304 | |
| 0.05 | 0.014 | 0.064 | Nociceptin (N/OFQ) receptor antagonist | 0.064 0.009 DBMET02304 0.042 0.019 DBMET00734 0.054 0.013 DBMET02305 | DBMET02304 | |
| 0.104 | 0.07 | 0.178 | Nav1.4 sodium channel blocker | 0.174 0.026 DBMET02304 0.115 0.057 DBMET00734 0.178 0.024 DBMET02305 | DBMET02305 | |
| 0.099 | 0.065 | 0.167 | 5-Lipoxygenase inhibitor | 0.108 0.058 DBMET02304 0.16 0.034 DBMET00734 0.167 0.032 DBMET02305 | DBMET02305 | |
| 0.109 | 0.075 | 0.109 | Microtubule formation inhibitor | 0.109 0.075 DBMET00734 | ||
| 0.051 | 0.017 | 0.066 | Beta adrenoreceptor agonist | 0.045 0.033 DBMET02304 0.066 0.006 DBMET00734 0.053 0.013 DBMET02305 | DBMET00734 | |
| 0.13 | 0.096 | 0.13 | Cholinergic | |||
| 0.038 | 0.004 | 0.038 | Alpha 2c adrenoreceptor agonist | 0.029 0.005 DBMET02304 0.02 0.01 DBMET00734 0.017 0.015 DBMET02305 | ||
| 0.094 | 0.061 | 0.134 | Prolactin inhibitor | 0.102 0.053 DBMET02304 0.129 0.033 DBMET00734 0.134 0.03 DBMET02305 | DBMET02305 | |
| 0.119 | 0.086 | 0.119 | Sodium channel (voltage-gated) blocker | 0.114 0.092 DBMET02304 | ||
| 0.109 | 0.076 | 0.184 | Adenylate cyclase inhibitor | 0.157 0.04 DBMET02304 0.136 0.055 DBMET00734 0.184 0.029 DBMET02305 0.101 0.083 DBMET02294 | DBMET02305 | |
| 0.099 | 0.068 | 0.101 | Nav1.1 sodium channel blocker | 0.101 0.065 DBMET00734 | DBMET00734 | |
| 0.036 | 0.005 | 0.042 | 1,3-Beta-glucan synthase inhibitor | 0.042 0.004 DBMET02304 0.036 0.005 DBMET00734 0.042 0.004 DBMET02305 0.04 0.004 DBMET02294 | DBMET02305 | |
| 0.097 | 0.067 | 0.141 | GABA C receptor rho-1 antagonist | 0.139 0.027 DBMET02304 0.087 0.084 DBMET00734 0.141 0.026 DBMET02305 | DBMET02305 | |
| 0.094 | 0.065 | 0.131 | Lanosterol 14 alpha demethylase inhibitor | 0.131 0.021 DBMET02304 0.13 0.022 DBMET02305 | DBMET02304 | |
| 0.087 | 0.059 | 0.123 | Ornithine decarboxylase inhibitor | 0.115 0.029 DBMET02304 0.096 0.049 DBMET00734 0.123 0.024 DBMET02305 0.082 0.065 DBMET02294 | DBMET02305 | |
| 0.171 | 0.144 | 0.47 | DNA damaging | 0.215 0.104 DBMET02304 0.175 0.14 DBMET00734 0.228 0.094 DBMET02305 0.47 0.017 DBMET02294 | DBMET02294 | |
| 0.048 | 0.022 | 0.048 | Histamine H1 receptor agonist | |||
| 0.057 | 0.031 | 0.057 | 5 Hydroxytryptamine 1B agonist | |||
| 0.048 | 0.028 | 0.048 | Histamine H3 receptor antagonist | |||
| 0.083 | 0.063 | 0.104 | Vanilloid agonist | 0.081 0.068 DBMET02304 0.104 0.029 DBMET00734 0.095 0.04 DBMET02305 | DBMET00734 | |
| 0.025 | 0.005 | 0.031 | Alpha 2b adrenoreceptor agonist | 0.031 0.004 DBMET02304 0.018 0.016 DBMET00734 0.023 0.007 DBMET02305 | DBMET02304 | |
| 0.153 | 0.134 | 0.153 | Potassium channel (Voltage-sensitive) blocker | |||
| 0.029 | 0.01 | 0.029 | Acid ceramidase inhibitor | |||
| 0.026 | 0.008 | 0.034 | Factor IX inhibitor | 0.034 0.005 DBMET02304 0.019 0.012 DBMET00734 0.027 0.007 DBMET02305 | DBMET02304 | |
| 0.048 | 0.031 | 0.048 | Benzodiazepine antagonist | |||
| 0.038 | 0.021 | 0.038 | Ceramide glucosyltransferase inhibitor | 0.033 0.029 DBMET00734 | ||
| 0.062 | 0.045 | 0.082 | 5 Hydroxytryptamine 2A agonist | 0.082 0.026 DBMET02304 0.056 0.051 DBMET00734 0.074 0.033 DBMET02305 | DBMET02304 | |
| 0.09 | 0.074 | 0.11 | Bile acid receptor antagonist | 0.099 0.051 DBMET02304 0.104 0.041 DBMET00734 0.11 0.031 DBMET02305 | DBMET02305 | |
| 0.189 | 0.174 | 0.23 | Insulysin inhibitor | 0.205 0.15 DBMET02304 0.207 0.146 DBMET00734 0.23 0.117 DBMET02305 | DBMET02305 | |
| 0.03 | 0.015 | 0.039 | Estrogen-related receptor gamma antagonist | 0.039 0.005 DBMET00734 0.031 0.015 DBMET02305 | DBMET00734 | |
| 0.025 | 0.01 | 0.051 | Imidazoline I1 receptor antagonist | 0.051 0.004 DBMET02304 0.023 0.012 DBMET02305 | DBMET02304 | |
| 0.118 | 0.103 | 0.168 | Cell wall synthesis inhibitor | 0.148 0.067 DBMET02304 0.129 0.088 DBMET00734 0.167 0.05 DBMET02305 0.168 0.049 DBMET02294 | DBMET02294 | |
| 0.05 | 0.035 | 0.053 | Squalene epoxidase inhibitor | 0.053 0.029 DBMET00734 | DBMET00734 | |
| 0.114 | 0.099 | 0.13 | Papain-like protease (SARS coronavirus) inhibitor | 0.13 0.06 DBMET00734 0.12 0.082 DBMET02305 | DBMET00734 | |
| 0.051 | 0.037 | 0.051 | 5 Hydroxytryptamine 2 agonist | 0.05 0.039 DBMET02304 | ||
| 0.062 | 0.049 | 0.062 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.027 | 0.014 | 0.03 | Vanilloid 2 agonist | 0.03 0.01 DBMET00734 0.024 0.022 DBMET02305 0.029 0.011 DBMET02294 | DBMET00734 | |
| 0.096 | 0.084 | 0.183 | GABA C receptor antagonist | 0.168 0.022 DBMET02304 0.093 0.089 DBMET00734 0.183 0.017 DBMET02305 | DBMET02305 | |
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | 0.043 0.037 DBMET00734 | ||
| 0.088 | 0.077 | 0.088 | Alpha 2d adrenoreceptor antagonist | |||
| 0.044 | 0.034 | 0.054 | Parathyroid hormone antagonist | 0.054 0.016 DBMET02304 0.047 0.026 DBMET02305 | DBMET02304 | |
| 0.091 | 0.081 | 0.184 | Ferrochelatase inhibitor | 0.184 0.026 DBMET02304 0.129 0.048 DBMET02305 | DBMET02304 | |
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.02 | 0.01 | 0.03 | Estrogen-related receptor gamma agonist | 0.03 0.004 DBMET00734 0.018 0.015 DBMET02305 | DBMET00734 | |
| 0.014 | 0.005 | 0.019 | Imidazoline I2 receptor antagonist | 0.019 0.004 DBMET02304 | DBMET02304 | |
| 0.048 | 0.039 | 0.048 | Alpha 1b adrenoreceptor agonist | 0.047 0.045 DBMET00734 | ||
| 0.068 | 0.059 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.066 0.065 DBMET02304 0.068 0.06 DBMET00734 | ||
| 0.073 | 0.065 | 0.099 | Interferon agonist | 0.099 0.03 DBMET02304 0.094 0.034 DBMET02305 | DBMET02304 | |
| 0.061 | 0.055 | 0.065 | Calcium channel P-type blocker | 0.065 0.039 DBMET02304 | DBMET02304 | |
| 0.196 | 0.191 | 0.196 | Calpain 2 inhibitor | |||
| 0.024 | 0.02 | 0.024 | Lysophosphatidic acid receptor 1 agonist | 0.024 0.02 DBMET02304 | ||
| 0.051 | 0.047 | 0.051 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.038 | 0.035 | 0.044 | Sphingosine 1-phosphate receptor 1 agonist | 0.044 0.027 DBMET02304 | DBMET02304 | |
| 0.02 | 0.017 | 0.02 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.08 | 0.078 | 0.127 | Aminoacyl-tRNA synthetase inhibitor | 0.12 0.03 DBMET02304 0.087 0.064 DBMET00734 0.127 0.027 DBMET02305 | DBMET02305 | |
| 0.083 | 0.081 | 0.085 | ABCA1 expression enhancer | 0.085 0.075 DBMET00734 | DBMET00734 | |
| 0.031 | 0.029 | 0.031 | Melatonin receptor 1A agonist | |||
| 0.02 | 0.019 | 0.022 | Leukotriene B4 receptor 2 antagonist | 0.022 0.016 DBMET00734 0.021 0.016 DBMET02305 | DBMET00734 | |
| 0.036 | 0.035 | 0.036 | Glutamate (mGluR1a) antagonist | |||
| 0.096 | 0.096 | 0.129 | Photosensitizer | 0.121 0.056 DBMET02304 0.098 0.092 DBMET00734 0.129 0.048 DBMET02305 0.115 0.064 DBMET02294 | DBMET02305 | |
| 0.024 | 0.024 | 0.03 | Endothelin receptor antagonist | 0.03 0.018 DBMET02304 | DBMET02304 | |
| 0.058 | 0.059 | 0.08 | Interferon inducer | 0.08 0.024 DBMET02304 0.077 0.026 DBMET02305 | DBMET02304 | |
| 0.048 | 0.049 | 0.119 | Alpha-mannosidase inhibitor | 0.049 0.046 DBMET00734 0.052 0.04 DBMET02305 0.119 0.005 DBMET02294 | DBMET02294 | |
| 0.078 | 0.08 | 0.107 | Triose-phosphate isomerase inhibitor | 0.107 0.041 DBMET02304 0.099 0.049 DBMET02305 | DBMET02304 | |
| 0.097 | 0.1 | 0.182 | Glutamate receptor antagonist | 0.179 0.034 DBMET02304 0.102 0.094 DBMET00734 0.182 0.032 DBMET02305 | DBMET02305 | |
| 0.02 | 0.022 | 0.028 | Beta 1 adrenoreceptor agonist | 0.028 0.009 DBMET00734 0.024 0.013 DBMET02305 | DBMET00734 | |
| 0.042 | 0.045 | 0.077 | NMDA 2A receptor antagonist | 0.046 0.041 DBMET02304 0.059 0.03 DBMET00734 0.077 0.021 DBMET02305 | DBMET02305 | |
| 0.049 | 0.053 | 0.054 | Epithelial sodium channel blocker | 0.054 0.039 DBMET02304 | DBMET02304 | |
| 0.072 | 0.077 | 0.098 | Histamine N-methyltransferase inhibitor | 0.098 0.048 DBMET02304 0.094 0.052 DBMET02305 | DBMET02304 | |
| 0.043 | 0.049 | 0.045 | Lysophosphatidic acid 3 receptor antagonist | 0.045 0.044 DBMET02304 | DBMET02304 | |
| 0.016 | 0.023 | 0.019 | Endothelin A receptor antagonist | 0.019 0.018 DBMET02304 | DBMET02304 | |
| 0.031 | 0.04 | 0.041 | Tryptophan 5 hydroxylase inhibitor | 0.041 0.013 DBMET02304 0.034 0.03 DBMET02305 | DBMET02304 | |
| 0.06 | 0.069 | 0.081 | Aminopeptidase I inhibitor | 0.077 0.045 DBMET02304 0.081 0.041 DBMET02305 | DBMET02305 | |
| 0.086 | 0.097 | 0.108 | Adenylate kinase inhibitor | 0.108 0.056 DBMET02304 0.103 0.062 DBMET02305 | DBMET02304 | |
| 0.024 | 0.035 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.019 DBMET02304 0.028 0.021 DBMET02305 | DBMET02304 | |
| 0.192 | 0.204 | 0.366 | Interleukin 2 agonist | 0.346 0.048 DBMET02304 0.249 0.119 DBMET00734 0.366 0.039 DBMET02305 0.342 0.049 DBMET02294 | DBMET02305 | |
| 0.068 | 0.081 | 0.092 | Androgen antagonist | 0.092 0.053 DBMET00734 0.079 0.066 DBMET02305 | DBMET00734 | |
| 0.067 | 0.082 | 0.14 | GABA B receptor agonist | 0.114 0.009 DBMET02304 0.082 0.037 DBMET00734 0.14 0.005 DBMET02305 | DBMET02305 | |
| 0.066 | 0.083 | 0.094 | Opioid kappa receptor antagonist | 0.094 0.041 DBMET00734 0.092 0.043 DBMET02305 | DBMET00734 | |
| 0.082 | 0.099 | 0.212 | Carbonic anhydrase XV inhibitor | 0.162 0.027 DBMET02304 0.1 0.067 DBMET00734 0.212 0.017 DBMET02305 | DBMET02305 | |
| 0.097 | 0.114 | 0.119 | Cathepsin H inhibitor | 0.119 0.077 DBMET02304 | DBMET02304 | |
| 0.03 | 0.047 | 0.051 | Oxytocin agonist | 0.038 0.034 DBMET02304 0.051 0.023 DBMET02305 | DBMET02305 | |
| 0.038 | 0.056 | 0.041 | Heme oxygenase inhibitor | 0.041 0.036 DBMET02304 | DBMET02304 | |
| 0.043 | 0.061 | 0.057 | Leukotriene B4 antagonist | 0.05 0.044 DBMET02304 0.051 0.043 DBMET00734 0.057 0.031 DBMET02305 | DBMET02305 | |
| 0.092 | 0.11 | 0.123 | Cyclooxygenase 1 inhibitor | 0.123 0.077 DBMET00734 0.122 0.078 DBMET02305 0.111 0.089 DBMET02294 | DBMET00734 | |
| 0.059 | 0.078 | 0.105 | Glutamate dehydrogenase inhibitor | 0.101 0.03 DBMET02304 0.105 0.028 DBMET02305 | DBMET02305 | |
| 0.11 | 0.13 | 0.195 | Phospholipase A2 inhibitor | 0.173 0.058 DBMET02304 0.126 0.107 DBMET00734 0.195 0.045 DBMET02305 | DBMET02305 | |
| 0.034 | 0.054 | 0.108 | Mannosidase inhibitor | 0.042 0.037 DBMET02304 0.046 0.031 DBMET02305 0.108 0.005 DBMET02294 | DBMET02294 | |
| 0.009 | 0.032 | 0.028 | Ileal bile acid transport inhibitor | 0.028 0.005 DBMET02294 | DBMET02294 | |
| 0.131 | 0.154 | 0.174 | Succinate dehydrogenase inhibitor | 0.167 0.085 DBMET02304 0.174 0.074 DBMET02305 | DBMET02305 | |
| 0.02 | 0.045 | 0.036 | Retinoid X receptor agonist | 0.036 0.025 DBMET02304 | DBMET02304 | |
| 0.095 | 0.122 | 0.152 | NADPH oxidase inhibitor | 0.118 0.086 DBMET02304 0.133 0.068 DBMET00734 0.152 0.053 DBMET02305 | DBMET02305 | |
| 0.083 | 0.111 | 0.107 | MAO inhibitor | 0.106 0.084 DBMET00734 0.107 0.083 DBMET02305 | DBMET02305 | |
| 0.047 | 0.075 | 0.057 | NMDA receptor agonist | 0.057 0.051 DBMET02304 0.057 0.052 DBMET02305 | DBMET02305 | |
| 0.015 | 0.043 | 0.021 | Dopamine D1 agonist | 0.021 0.018 DBMET00734 | DBMET00734 | |
| 0.07 | 0.099 | 0.137 | Transcription factor NF kappa B stimulant | 0.079 0.071 DBMET02305 0.137 0.019 DBMET02294 | DBMET02294 | |
| 0.071 | 0.102 | 0.109 | ATPase (Vacuolar H+) inhibitor | 0.085 0.068 DBMET00734 0.109 0.029 DBMET02294 | DBMET02294 | |
| 0.029 | 0.063 | 0.044 | 5 Hydroxytryptamine 2B agonist | 0.044 0.018 DBMET02304 | DBMET02304 | |
| 0.059 | 0.093 | 0.078 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.078 0.042 DBMET02304 | DBMET02304 | |
| 0.097 | 0.131 | 0.429 | Peroxidase inhibitor | 0.259 0.046 DBMET02304 0.214 0.056 DBMET00734 0.429 0.017 DBMET02305 | DBMET02305 | |
| 0.024 | 0.059 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.018 DBMET02305 | DBMET02305 | |
| 0.052 | 0.087 | 0.078 | Cathepsin G inhibitor | 0.076 0.048 DBMET02304 0.078 0.045 DBMET02305 | DBMET02305 | |
| 0.037 | 0.073 | 0.057 | Dopamine beta hydroxylase inhibitor | 0.05 0.03 DBMET02304 0.057 0.018 DBMET02305 | DBMET02305 | |
| 0.032 | 0.068 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 DBMET02305 | DBMET02305 | |
| 0.024 | 0.061 | 0.08 | Urokinase inhibitor | 0.08 0.021 DBMET02304 0.068 0.025 DBMET02305 | DBMET02304 | |
| 0.063 | 0.101 | 0.11 | Opioid antagonist | 0.1 0.048 DBMET00734 0.11 0.041 DBMET02305 | DBMET02305 | |
| 0.064 | 0.103 | 0.155 | Aminopeptidase B inhibitor | 0.145 0.04 DBMET02304 0.155 0.036 DBMET02305 | DBMET02305 | |
| 0.017 | 0.055 | 0.028 | Thyroid hormone agonist | 0.024 0.021 DBMET00734 0.028 0.014 DBMET02305 | DBMET02305 | |
| 0.012 | 0.051 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.012 DBMET02305 | DBMET02305 | |
| 0.162 | 0.201 | 0.211 | Neuropeptide Y2 antagonist | 0.209 0.104 DBMET02304 0.211 0.102 DBMET02305 | DBMET02305 | |
| 0.014 | 0.055 | 0.024 | Urotensin II agonist | 0.024 0.023 DBMET02305 | DBMET02305 | |
| 0.05 | 0.09 | 0.21 | Glutamate decarboxylase inhibitor | 0.151 0.013 DBMET02304 0.079 0.045 DBMET00734 0.21 0.006 DBMET02305 | DBMET02305 | |
| 0.086 | 0.127 | 0.155 | Aldehyde dehydrogenase inhibitor | 0.111 0.081 DBMET02304 0.111 0.082 DBMET00734 0.155 0.044 DBMET02305 0.121 0.07 DBMET02294 | DBMET02305 | |
| 0.055 | 0.098 | 0.143 | Somatostatin 1 agonist | 0.135 0.018 DBMET02304 0.069 0.066 DBMET00734 0.143 0.015 DBMET02305 | DBMET02305 | |
| 0.061 | 0.106 | 0.081 | MAO A inhibitor | 0.081 0.079 DBMET00734 | DBMET00734 | |
| 0.025 | 0.07 | 0.064 | Antibiotic Aminoglycoside-like | 0.033 0.03 DBMET02304 0.035 0.027 DBMET02305 0.064 0.007 DBMET02294 | DBMET02294 | |
| 0.111 | 0.158 | 0.153 | Interferon gamma antagonist | 0.13 0.111 DBMET00734 0.14 0.092 DBMET02305 0.153 0.074 DBMET02294 | DBMET02294 | |
| 0.033 | 0.08 | 0.049 | Toll-Like receptor 8 antagonist | 0.049 0.042 DBMET02304 | DBMET02304 | |
| 0.023 | 0.073 | 0.081 | Dopamine D5 agonist | 0.052 0.016 DBMET02304 0.039 0.029 DBMET00734 0.081 0.006 DBMET02305 | DBMET02305 | |
| 0.047 | 0.097 | 0.056 | Ryanodine receptor antagonist | 0.055 0.054 DBMET02304 0.056 0.049 DBMET02305 | DBMET02305 | |
| 0.102 | 0.154 | 0.13 | Arachidonic acid antagonist | 0.123 0.122 DBMET02304 0.13 0.113 DBMET02305 | DBMET02305 | |
| 0.045 | 0.097 | 0.11 | Na+ K+ transporting ATPase inhibitor | 0.095 0.037 DBMET02304 0.102 0.03 DBMET02305 0.11 0.023 DBMET02294 | DBMET02294 | |
| 0.052 | 0.107 | 0.075 | Exportin-1 inhibitor | 0.075 0.032 DBMET02304 | DBMET02304 | |
| 0.074 | 0.131 | 0.155 | M18 aspartyl aminopeptidase inhibitor | 0.155 0.05 DBMET00734 0.109 0.082 DBMET02305 | DBMET00734 | |
| 0.066 | 0.124 | 0.234 | GABA C receptor agonist | 0.234 0.015 DBMET02304 0.23 0.016 DBMET02305 | DBMET02304 | |
| 0.123 | 0.183 | 0.368 | Immunostimulant | 0.207 0.116 DBMET02304 0.165 0.143 DBMET00734 0.262 0.091 DBMET02305 0.368 0.059 DBMET02294 | DBMET02294 | |
| 0.072 | 0.134 | 0.103 | Cholesterol synthesis inhibitor | 0.103 0.084 DBMET02305 | DBMET02305 | |
| 0.033 | 0.095 | 0.072 | Glucagon-like peptide 1 agonist | 0.072 0.04 DBMET02304 0.072 0.04 DBMET02305 | DBMET02305 | |
| 0.12 | 0.184 | 0.219 | Phospholipase C inhibitor | 0.18 0.061 DBMET02304 0.15 0.106 DBMET00734 0.219 0.034 DBMET02305 | DBMET02305 | |
| 0.053 | 0.117 | 0.083 | Myeloperoxidase inhibitor | 0.083 0.06 DBMET02305 | DBMET02305 | |
| 0.122 | 0.188 | 0.17 | Neurotensin receptor agonist | 0.15 0.102 DBMET02304 0.139 0.132 DBMET00734 0.17 0.062 DBMET02305 | DBMET02305 | |
| 0.032 | 0.098 | 0.054 | Aconitate hydratase inhibitor | 0.054 0.033 DBMET02304 | DBMET02304 | |
| 0.046 | 0.114 | 0.064 | Glutamate (mGluR7) antagonist | 0.064 0.055 DBMET02304 | DBMET02304 | |
| 0.028 | 0.098 | 0.061 | Maillard reaction inhibitor | 0.061 0.034 DBMET02305 | DBMET02305 | |
| 0.093 | 0.163 | 0.145 | DNA repair enzyme inhibitor | 0.145 0.036 DBMET02294 | DBMET02294 | |
| 0.06 | 0.132 | 0.163 | Creatine kinase inhibitor | 0.107 0.053 DBMET02304 0.09 0.072 DBMET00734 0.163 0.019 DBMET02305 | DBMET02305 | |
| 0.021 | 0.094 | 0.047 | Guanylate cyclase inhibitor | 0.047 0.024 DBMET02304 0.038 0.037 DBMET02305 | DBMET02304 | |
| 0.051 | 0.126 | 0.089 | Glycine receptor antagonist | 0.089 0.044 DBMET02294 | DBMET02294 | |
| 0.086 | 0.162 | 0.141 | Transcription factor STAT6 inhibitor | 0.132 0.041 DBMET02304 0.141 0.031 DBMET02305 | DBMET02305 | |
| 0.032 | 0.108 | 0.117 | NMDA 2 receptor antagonist | 0.065 0.056 DBMET02304 0.117 0.025 DBMET02305 | DBMET02305 | |
| 0.056 | 0.132 | 0.093 | Mediator release inhibitor | 0.087 0.085 DBMET02305 0.093 0.078 DBMET02294 | DBMET02294 | |
| 0.025 | 0.102 | 0.07 | Protein 50S ribosomal subunit inhibitor | 0.07 0.024 DBMET02294 | DBMET02294 | |
| 0.027 | 0.103 | 0.085 | Opioid delta receptor antagonist | 0.062 0.045 DBMET00734 0.085 0.035 DBMET02305 | DBMET02305 | |
| 0.036 | 0.113 | 0.048 | Vanilloid 2 antagonist | 0.048 0.046 DBMET00734 | DBMET00734 | |
| 0.063 | 0.142 | 0.183 | Carbonic anhydrase III inhibitor | 0.121 0.043 DBMET02304 0.091 0.073 DBMET00734 0.183 0.019 DBMET02305 | DBMET02305 | |
| 0.056 | 0.135 | 0.134 | HIV-1 integrase (Overall Integration) inhibitor | 0.124 0.037 DBMET02304 0.134 0.032 DBMET02305 | DBMET02305 | |
| 0.119 | 0.199 | 0.145 | Heat shock protein 70 antagonist | 0.135 0.094 DBMET02304 0.145 0.057 DBMET02305 | DBMET02305 | |
| 0.047 | 0.127 | 0.087 | Protein kinase A inhibitor | 0.087 0.055 DBMET02304 0.078 0.062 DBMET02305 | DBMET02304 | |
| 0.031 | 0.112 | 0.085 | Opioid mu receptor antagonist | 0.064 0.05 DBMET00734 0.085 0.037 DBMET02305 | DBMET02305 | |
| 0.029 | 0.112 | 0.335 | Selectin antagonist | 0.335 0.004 DBMET02294 | DBMET02294 | |
| 0.06 | 0.143 | 0.088 | NADH dehydrogenase inhibitor | 0.083 0.068 DBMET02304 0.088 0.059 DBMET02305 0.088 0.06 DBMET02294 | DBMET02294 | |
| 0.048 | 0.132 | 0.074 | Glutamate (mGluR6) antagonist | 0.074 0.032 DBMET02304 0.069 0.041 DBMET02305 | DBMET02304 | |
| 0.076 | 0.16 | 0.176 | Toll-Like receptor 2 antagonist | 0.128 0.07 DBMET02304 0.118 0.08 DBMET00734 0.176 0.036 DBMET02305 | DBMET02305 | |
| 0.108 | 0.194 | 0.21 | Non-steroidal antiinflammatory agent | 0.21 0.063 DBMET02294 | DBMET02294 | |
| 0.02 | 0.106 | 0.055 | Ornithine carbamoyltransferase inhibitor | 0.055 0.035 DBMET02304 0.05 0.039 DBMET02305 | DBMET02304 | |
| 0.139 | 0.227 | 0.235 | DNA synthesis inhibitor | 0.19 0.139 DBMET02305 0.235 0.078 DBMET02294 | DBMET02294 | |
| 0.045 | 0.133 | 0.123 | GABA aminotransferase inhibitor | 0.099 0.028 DBMET02304 0.123 0.015 DBMET02305 | DBMET02305 | |
| 0.103 | 0.196 | 0.149 | CF transmembrane conductance regulator agonist | 0.128 0.124 DBMET02304 0.149 0.077 DBMET02305 | DBMET02305 | |
| 0.014 | 0.109 | 0.048 | Vascular adhesion protein 1 inhibitor | 0.048 0.017 DBMET02304 | DBMET02304 | |
| 0.057 | 0.152 | 0.103 | UDP-glucose 4-epimerase inhibitor | 0.103 0.057 DBMET02294 | DBMET02294 | |
| 0.053 | 0.149 | 0.074 | Estrogen receptor alpha antagonist | 0.074 0.06 DBMET00734 0.07 0.067 DBMET02305 | DBMET00734 | |
| 0.009 | 0.106 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET02294 | DBMET02294 | |
| 0.012 | 0.109 | 0.038 | Phosphoglycerate kinase inhibitor | 0.034 0.026 DBMET02304 0.038 0.021 DBMET02305 | DBMET02305 | |
| 0.129 | 0.228 | 0.335 | Superoxide dismutase inhibitor | 0.275 0.061 DBMET02304 0.168 0.158 DBMET00734 0.335 0.04 DBMET02305 | DBMET02305 | |
| 0.012 | 0.113 | 0.029 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 DBMET02294 | DBMET02294 | |
| 0.061 | 0.163 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.063 DBMET02305 | DBMET02305 | |
| 0.01 | 0.114 | 0.021 | Somatostatin 4 antagonist | 0.021 0.019 DBMET02304 0.021 0.019 DBMET02305 | DBMET02305 | |
| 0.098 | 0.206 | 0.125 | Sphingosine 1-phosphate receptor 5 antagonist | 0.125 0.113 DBMET02304 | DBMET02304 | |
| 0.082 | 0.189 | 0.233 | Amyloid beta aggregation inhibitor | 0.196 0.08 DBMET00734 0.189 0.084 DBMET02305 0.233 0.063 DBMET02294 | DBMET02294 | |
| 0.081 | 0.19 | 0.113 | Neurotrophic factor | 0.113 0.107 DBMET02294 | DBMET02294 | |
| 0.045 | 0.154 | 0.122 | Glycine receptor agonist | 0.112 0.015 DBMET02304 0.122 0.012 DBMET02305 | DBMET02305 | |
| 0.045 | 0.155 | 0.06 | Transcription factor RelA inhibitor | 0.059 0.058 DBMET02304 0.06 0.056 DBMET02305 | DBMET02305 | |
| 0.056 | 0.166 | 0.088 | MAP kinase kinase 7 inhibitor | 0.073 0.069 DBMET02304 0.088 0.027 DBMET02305 | DBMET02305 | |
| 0.037 | 0.15 | 0.06 | Corticotropin releasing factor 2 receptor antagonist | 0.06 0.046 DBMET02304 | DBMET02304 | |
| 0.056 | 0.169 | 0.092 | 5 Hydroxytryptamine 3A agonist | 0.092 0.087 DBMET02304 | DBMET02304 | |
| 0.031 | 0.149 | 0.14 | Porphobilinogen synthase inhibitor | 0.111 0.031 DBMET02304 0.14 0.023 DBMET02305 | DBMET02305 | |
| 0.065 | 0.182 | 0.103 | Phosphodiesterase 6D inhibitor | 0.103 0.046 DBMET02294 | DBMET02294 | |
| 0.019 | 0.137 | 0.087 | NMDA 2C receptor antagonist | 0.066 0.037 DBMET02304 0.087 0.021 DBMET02305 | DBMET02305 | |
| 0.029 | 0.151 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.048 DBMET02305 | DBMET02305 | |
| 0.01 | 0.134 | 0.035 | Protein 30S ribosomal subunit inhibitor | 0.035 0.011 DBMET02294 | DBMET02294 | |
| 0.024 | 0.148 | 0.052 | Biliverdin reductase inhibitor | 0.052 0.051 DBMET02304 | DBMET02304 | |
| 0.016 | 0.145 | 0.047 | Growth hormone release inhibitor | 0.045 0.025 DBMET02304 0.047 0.024 DBMET02305 | DBMET02305 | |
| 0.044 | 0.176 | 0.092 | Keratolytic | 0.092 0.036 DBMET02305 | DBMET02305 | |
| 0.038 | 0.17 | 0.187 | Monophenol monooxygenase inhibitor | 0.093 0.082 DBMET00734 0.148 0.048 DBMET02305 0.187 0.036 DBMET02294 | DBMET02294 | |
| 0.007 | 0.141 | 0.023 | Somatostatin 2 antagonist | 0.023 0.022 DBMET02304 | DBMET02304 | |
| 0.013 | 0.15 | 0.053 | Somatostatin 1 antagonist | 0.052 0.019 DBMET02304 0.053 0.019 DBMET02305 | DBMET02305 | |
| 0.02 | 0.158 | 0.136 | Alcohol oxidase inhibitor | 0.071 0.028 DBMET02304 0.136 0.012 DBMET02305 | DBMET02305 | |
| 0.013 | 0.152 | 0.034 | Glutamate (mGluR group II) antagonist | 0.034 0.033 DBMET02304 | DBMET02304 | |
| 0.084 | 0.224 | 0.379 | Nitric oxide antagonist | 0.135 0.111 DBMET00734 0.142 0.103 DBMET02305 0.379 0.028 DBMET02294 | DBMET02294 | |
| 0.037 | 0.178 | 0.084 | Macrophage migration inhibitory factor inhibitor | 0.084 0.047 DBMET02305 | DBMET02305 | |
| 0.024 | 0.164 | 0.052 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.052 0.039 DBMET02305 | DBMET02305 | |
| 0.059 | 0.201 | 0.255 | Lipid peroxidase inhibitor | 0.153 0.066 DBMET00734 0.142 0.074 DBMET02305 0.255 0.026 DBMET02294 | DBMET02294 | |
| 0.085 | 0.228 | 0.393 | Hepatoprotectant | 0.133 0.129 DBMET02305 0.393 0.014 DBMET02294 | DBMET02294 | |
| 0.012 | 0.165 | 0.052 | Carbonic anhydrase VB inhibitor | 0.052 0.043 DBMET02305 | DBMET02305 | |
| 0.083 | 0.237 | 0.145 | Hemostatic | 0.131 0.094 DBMET02304 0.136 0.087 DBMET02305 0.145 0.074 DBMET02294 | DBMET02294 | |
| 0.169 | 0.323 | 0.623 | Apoptosis agonist | 0.277 0.189 DBMET00734 0.623 0.044 DBMET02294 | DBMET02294 | |
| 0.04 | 0.195 | 0.108 | Carbonic anhydrase VI inhibitor | 0.074 0.065 DBMET02304 0.108 0.035 DBMET02305 | DBMET02305 | |
| 0.046 | 0.206 | 0.124 | Cystathionine beta-synthase inhibitor | 0.124 0.055 DBMET02305 | DBMET02305 | |
| 0.117 | 0.282 | 0.197 | Transcription factor STAT3 inhibitor | 0.189 0.149 DBMET02304 0.197 0.137 DBMET02305 | DBMET02305 | |
| 0.125 | 0.294 | 0.451 | Immunosuppressant | 0.205 0.192 DBMET02305 0.451 0.047 DBMET02294 | DBMET02294 | |
| 0.095 | 0.264 | 0.581 | Antioxidant | 0.239 0.09 DBMET00734 0.245 0.086 DBMET02305 0.581 0.013 DBMET02294 | DBMET02294 | |
| 0.049 | 0.221 | 0.413 | Amylase inhibitor | 0.111 0.088 DBMET02304 0.2 0.044 DBMET02305 0.413 0.009 DBMET02294 | DBMET02294 | |
| 0.078 | 0.251 | 0.27 | Growth hormone agonist | 0.248 0.044 DBMET02304 0.27 0.039 DBMET02305 | DBMET02305 | |
| 0.018 | 0.192 | 0.137 | Antineoplastic antibiotic | 0.137 0.034 DBMET02294 | DBMET02294 | |
| 0.024 | 0.198 | 0.123 | Histidine decarboxylase inhibitor | 0.07 0.05 DBMET02304 0.123 0.025 DBMET02305 | DBMET02305 | |
| 0.061 | 0.244 | 0.132 | Interleukin 4 antagonist | 0.123 0.081 DBMET00734 0.132 0.069 DBMET02305 0.13 0.071 DBMET02294 | DBMET02305 | |
| 0.043 | 0.226 | 0.108 | Chelator | 0.096 0.084 DBMET00734 0.108 0.066 DBMET02294 | DBMET02294 | |
| 0.057 | 0.241 | 0.13 | Estrogen antagonist | 0.13 0.039 DBMET00734 0.127 0.042 DBMET02305 | DBMET00734 | |
| 0.115 | 0.306 | 0.176 | RNA-directed DNA polymerase inhibitor | 0.176 0.14 DBMET02305 | DBMET02305 | |
| 0.005 | 0.209 | 0.041 | Somatostatin 5 antagonist | 0.041 0.017 DBMET02304 0.041 0.018 DBMET02305 | DBMET02305 | |
| 0.047 | 0.253 | 0.079 | Interleukin 5 antagonist | 0.079 0.075 DBMET02305 | DBMET02305 | |
| 0.014 | 0.222 | 0.03 | Estrogen-related receptor beta antagonist | 0.03 0.029 DBMET02305 | DBMET02305 | |
| 0.023 | 0.24 | 0.087 | Carbonic anhydrase XIII inhibitor | 0.087 0.045 DBMET02305 | DBMET02305 | |
| 0.035 | 0.258 | 0.057 | Lipocortins synthesis agonist | 0.057 0.043 DBMET02294 | DBMET02294 | |
| 0.045 | 0.269 | 0.11 | Bone formation stimulant | 0.11 0.095 DBMET02305 | DBMET02305 | |
| 0.031 | 0.259 | 0.08 | Adenine nucleotide translocase inhibitor | 0.08 0.009 DBMET02294 | DBMET02294 | |
| 0.017 | 0.247 | 0.054 | NMDA 2B receptor antagonist | 0.054 0.037 DBMET02305 | DBMET02305 | |
| 0.069 | 0.302 | 0.216 | Interleukin 6 antagonist | 0.139 0.107 DBMET02305 0.216 0.033 DBMET02294 | DBMET02294 | |
| 0.013 | 0.247 | 0.054 | Neuraminidase inhibitor | 0.054 0.052 DBMET02294 | DBMET02294 | |
| 0.048 | 0.292 | 0.109 | DOPA decarboxylase inhibitor | 0.109 0.06 DBMET02305 | DBMET02305 | |
| 0.096 | 0.343 | 0.213 | Transcription factor STAT inhibitor | 0.199 0.14 DBMET02304 0.213 0.12 DBMET02305 | DBMET02305 | |
| 0.018 | 0.267 | 0.072 | Neuraminidase (influenza) inhibitor | 0.072 0.033 DBMET02294 | DBMET02294 | |
| 0.115 | 0.365 | 0.495 | Antibacterial | 0.274 0.155 DBMET02305 0.495 0.042 DBMET02294 | DBMET02294 | |
| 0.005 | 0.256 | 0.066 | Kinesin antagonist | 0.056 0.015 DBMET02304 0.066 0.013 DBMET02305 | DBMET02305 | |
| 0.005 | 0.256 | 0.066 | Kinesin-like protein 1 inhibitor | 0.056 0.015 DBMET02304 0.066 0.013 DBMET02305 | DBMET02305 | |
| 0.117 | 0.378 | 0.262 | Caspase 3 stimulant | 0.262 0.102 DBMET02294 | DBMET02294 | |
| 0.046 | 0.309 | 0.414 | Angiogenesis stimulant | 0.212 0.088 DBMET02305 0.414 0.02 DBMET02294 | DBMET02294 | |
| 0.063 | 0.327 | 0.509 | Free radical scavenger | 0.208 0.091 DBMET00734 0.208 0.091 DBMET02305 0.509 0.015 DBMET02294 | DBMET02294 | |
| 0.012 | 0.279 | 0.045 | Somatostatin 5 agonist | 0.045 0.015 DBMET02304 0.04 0.018 DBMET02305 | DBMET02304 | |
| 0.036 | 0.309 | 0.112 | Estrogen receptor beta antagonist | 0.112 0.042 DBMET00734 0.112 0.042 DBMET02305 | DBMET02305 | |
| 0.036 | 0.31 | 0.09 | Xanthine oxidase inhibitor | 0.09 0.071 DBMET02294 | DBMET02294 | |
| 0.03 | 0.324 | 0.075 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.075 0.072 DBMET02305 | DBMET02305 | |
| 0.03 | 0.354 | 0.121 | Beta glucuronidase inhibitor | 0.121 0.045 DBMET02294 | DBMET02294 | |
| 0.035 | 0.386 | 0.172 | Toll-Like receptor 4 antagonist | 0.094 0.081 DBMET02305 0.172 0.012 DBMET02294 | DBMET02294 | |
| 0.044 | 0.413 | 0.142 | Platelet adhesion inhibitor | 0.142 0.116 DBMET02294 | DBMET02294 | |
| 0.047 | 0.429 | 0.472 | Tumour necrosis factor alpha release inhibitor | 0.472 0.017 DBMET02294 | DBMET02294 | |
| 0.087 | 0.475 | 0.339 | Apoptosis antagonist | 0.339 0.061 DBMET02294 | DBMET02294 | |
| 0.11 | 0.5 | 0.698 | Antiinflammatory | 0.698 0.031 DBMET02294 | DBMET02294 | |
| 0.016 | 0.414 | 0.078 | Topoisomerase II alpha inhibitor | 0.078 0.054 DBMET02294 | DBMET02294 | |
| 0.026 | 0.443 | 0.15 | Thioredoxin inhibitor | 0.15 0.017 DBMET02294 | DBMET02294 | |
| 0.038 | 0.478 | 0.365 | Alpha-glucosidase inhibitor | 0.365 0.129 DBMET02294 | DBMET02294 | |
| 0.061 | 0.512 | 0.183 | Death-associated protein kinase 2 inhibitor | 0.167 0.072 DBMET02304 0.183 0.05 DBMET02305 | DBMET02305 | |
| 0.014 | 0.47 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.026 DBMET02294 | DBMET02294 | |
| 0.019 | 0.516 | 0.174 | Thrombolytic | 0.132 0.097 DBMET02305 0.174 0.065 DBMET02294 | DBMET02294 | |
| 0.013 | 0.529 | 0.134 | Topoisomerase II inhibitor | 0.134 0.057 DBMET02294 | DBMET02294 | |
| 0.012 | 0.547 | 0.123 | Topoisomerase I inhibitor | 0.123 0.054 DBMET02294 | DBMET02294 | |
| 0.032 | 0.643 | 0.092 | Interleukin 12 antagonist | 0.092 0.069 DBMET02294 | DBMET02294 | |
| 0.008 | 0.797 | 0.097 | Histone deacetylase stimulant | 0.097 0.03 DBMET02294 | DBMET02294 | |
| 0.008 | 0.797 | 0.097 | Histone deacetylase SIRT1 stimulant | 0.097 0.03 DBMET02294 | DBMET02294 | |
| 0.027 | 0.819 | 0.353 | NOS3 expression enhancer | 0.353 0.011 DBMET02294 | DBMET02294 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |